“The use of AI in the drug product life cycle continues to increase,” says Dr. Barima Frempong, a regulatory affairs analyst at the Defense Health Agency Research and Development-Medical ...

There is, furthermore, a persistent feeling that the life cycle concept adds luster and believability to the insistent claim in certain circles that marketing is close to being some sort of science.

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...